World's Best Scientists 2026 revealed!
David A. M. C. van de Vijver

David A. M. C. van de Vijver

D-Index & Metrics

Microbiology

D-Index
43
Citations
10632
World Ranking
5203
National Ranking
194

David A. M. C. van de Vijver publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where David A. M. C. van de Vijver sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 265 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 234 scientists 205–214 publications: 208 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 169 publications — 35th percentile

35% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

David A. M. C. van de Vijver D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where David A. M. C. van de Vijver sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 112 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 123 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 94 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 43 D-Index — 6th percentile

6% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

David A. M. C. van de Vijver is affiliated with Erasmus University Rotterdam in the Netherlands. Their research primarily spans the field of Medicine, with a focus on Infectious Diseases, Epidemiology, Molecular Biology, Virology, and Emergency Medicine.

Their scholarly work includes extensive contributions to topics such as HIV/AIDS research and interventions, HIV research and treatment, HIV/AIDS drug development and treatment, muscle physiology and disorders, HIV, drug use, and sexual risk, as well as SARS-CoV-2 and COVID-19 research and detection.

Frequent co-authors collaborating with van de Vijver include:

  • Jeroen J. A. van Kampen
  • Annemieke Aartsma-Rus
  • Charles A. Boucher
  • Marion Koopmans
  • Kai J. Jonas

Their publications have appeared often in several scientific venues, including:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Neuromuscular Disorders
  • Viruses
  • The Lancet HIV
  • Journal of the International AIDS Society

Some recent notable papers authored or co-authored by van de Vijver are:

  • "Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19)" (2021), published in Nature Communications
  • "Shedding of infectious virus in hospitalized patients with coronavirus disease-2019 (COVID-19): duration and key determinants" (2020), published in bioRxiv (Cold Spring Harbor Laboratory)
  • "Clinical Evaluation of Roche SD Biosensor Rapid Antigen Test for SARS-CoV-2 in Municipal Health Service Testing Site, the Netherlands" (2021), published in Emerging infectious diseases
  • "Predicted effects of the introduction of long-acting injectable cabotegravir pre-exposure prophylaxis in sub-Saharan Africa: a modelling study" (2023), published in The Lancet HIV
  • "Quality of life among people living with HIV in England and the Netherlands: a population-based study" (2021), published in The Lancet Regional Health - Europe

Best Publications

  • Drug Resistance Mutations for Surveillance of Transmitted HIV-1 Drug-Resistance: 2009 Update

    Diane E. Bennett;Ricardo J. Camacho;Dan Otelea;Daniel R. Kuritzkes

  • Pathogenesis and Transmission of Swine-Origin 2009 A(H1N1) Influenza Virus in Ferrets

    Vincent J. Munster;Emmie de Wit;Judith M. A. van den Brand;Sander Herfst

  • Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19).

    Jeroen J. A. van Kampen;David A. M. C. van de Vijver;Pieter L. A. Fraaij;Bart L. Haagmans

  • An automated genotyping system for analysis of HIV-1 and other microbial sequences

    Tulio De Oliveira;Koen Deforche;Sharon Cassol;Mika Salminen

  • Prevalence of Drug-Resistant HIV-1 Variants in Untreated Individuals in Europe: Implications for Clinical Management

    Annemarie M. J. Wensing;David A. van de Vijver;Gioacchino Angarano;Birgitta Åsjö

  • Reduction in Acquisition of Vancomycin-Resistant Enterococcus after Enforcement of Routine Environmental Cleaning Measures

    Mary K. Hayden;Marc J. M. Bonten;Donald W. Blom;Elizabeth A. Lyle

  • Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study

    Homie Razavi;Sarah Robbins;Stefan Zeuzem;Francesco Negro

  • Transmission of Drug-Resistant HIV-1 Is Stabilizing in Europe

    Jurgen Vercauteren;Annemarie M. J. Wensing;David A. M. C. van de Vijver;Jan Albert

  • Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient- and sequence-level meta-analysis

    Soo Yon Rhee;Jose Luis Blanco;Michael R. Jordan;Jonathan Taylor

  • Shedding of infectious virus in hospitalized patients with coronavirus disease-2019 (COVID-19): duration and key determinants

    Jeroen J.A. van Kampen;David A.M.C. van de Vijver;Pieter L.A. Fraaij;Bart L. Haagmans

  • Temporal changes in the epidemiology of transmission of drug-resistant HIV-1 across the world

    Dineke Frentz;Charles A B Boucher;David A M C van de Vijver

  • Declining Hepatitis C Virus (HCV) Incidence in Dutch Human Immunodeficiency Virus-Positive Men Who Have Sex With Men After Unrestricted Access to HCV Therapy

    Anne Boerekamps;Guido E van den Berk;Fanny N Lauw;Eliane M Leyten

  • Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: A combined analysis of 12 mathematical models

    Jeffrey W. Eaton;Nicolas A. Menzies;John Stover;Valentina Cambiano

  • Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe

    L. Marije Hofstra;Nicolas Sauvageot;Jan Albert;Jan Albert;Ivailo Alexiev

  • HIV-1 subtype distribution and its demographic determinants in newly diagnosed patients in Europe suggest highly compartmentalized epidemics

    Ana B. Abecasis;Annemarie M.J. Wensing;Dimitris Paraskevis;Jurgen Vercauteren;Jurgen Vercauteren

  • Sustainable HIV Treatment in Africa through Viral Load-Informed Differentiated Care

    Andrew Phillips;Amir Shroufi;Lara Vojnov;Jennifer Cohn

  • Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach

    Dimitrios Paraskevis;Dimitrios Paraskevis;Oliver Pybus;Gkikas Magiorkinis;Angelos Hatzakis

  • The calculated genetic barrier for antiretroviral drug resistance substitutions is largely similar for different HIV-1 subtypes

    David A van de Vijver;Annemarie M J Wensing;Gioacchino Angarano;Birgitta Asjö

  • Cost-effectiveness analysis of pre-exposure prophylaxis for HIV-1 prevention in the Netherlands: a mathematical modelling study

    Brooke E Nichols;Charles A B Boucher;Marc van der Valk;Bart J A Rijnders

  • Acyclovir Prophylaxis Predisposes to Antiviral Resistant Recurrent Herpetic Keratitis

    Monique van Velzen;David A. M. C. van de Vijver;Freek B. van Loenen;Albert D. M. E. Osterhaus

  • Antiretroviral therapy optimisation without genotype resistance testing: a perspective on treatment history based models

    Mattia C. F. Prosperi;Mattia C. F. Prosperi;Michal Rosen-Zvi;André Altmann;Maurizio Zazzi

Frequent Co-Authors

Charles A. Boucher
Charles A. Boucher Erasmus University Rotterdam
Anne-Mieke Vandamme
Anne-Mieke Vandamme Rega Institute for Medical Research
Anders Sönnerborg
Anders Sönnerborg Karolinska Institute
Jan Albert
Jan Albert Karolinska Institute
Dimitrios Paraskevis
Dimitrios Paraskevis National and Kapodistrian University of Athens
Peter M. A. Sloot
Peter M. A. Sloot University of Amsterdam
Claudia Balotta
Claudia Balotta University of Milan
Annemarie M. J. Wensing
Annemarie M. J. Wensing Utrecht University
Kristel Van Laethem
Kristel Van Laethem Rega Institute for Medical Research
Marion Koopmans
Marion Koopmans Erasmus University Rotterdam

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students studying Microbiology in the USA, exploring related healthcare and information management fields can broaden career opportunities. Many professionals transition into roles like medical coding, health information management, and related healthcare administration fields, which blend knowledge of science with data-driven management.

One valuable certification is the professional coder certification, which equips graduates to work efficiently with medical records and billing systems. This credential enhances job prospects in hospitals, clinics, and insurance companies.

Health Information Managers play a critical role in organizing and safeguarding patient information. Understanding the health information management salary trends helps gauge the financial benefits of entering this sector.

Students seeking formal education can find top-tier options through the best online cahiim accredited health information management degree programs, which ensure quality learning aligned with industry standards.

For faster entry into healthcare administration roles, pursuing a medical billing and coding certificate online accelerated can be an effective pathway, providing essential skills in an expedited format.

Best Scientists Citing David A. M. C. van de Vijver

Trending Scientists

Recently Published Articles